Monte Rosa Therapeutics, Inc.

GLUE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$224,254$128,101$54,912$346,071
Short-Term Investments$147,895$104,312$207,914$0
Receivables$173$505$7,656$0
Inventory$0$0$0$0
Other Curr. Assets$5,118$3,294$5,404$2,595
Total Curr. Assets$377,440$236,212$275,886$348,666
Property Plant & Equip (Net)$56,314$62,611$61,907$12,325
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$5,338
Tax Assets$0$0$0$0
Other NC Assets$4,978$4,932$4,596$0
Total NC Assets$61,292$67,543$66,503$17,663
Other Assets$0$0$0$0
Total Assets$438,732$303,755$342,389$366,329
Liabilities
Payables$17,215$11,152$7,862$6,558
Short-Term Debt$3,714$3,162$3,127$0
Tax Payable$0$0$0$0
Deferred Revenue$117,232$17,678$0$0
Other Curr. Liab.$18,785$14,600$14,580$10,080
Total Curr. Liab.$156,946$46,592$25,569$16,638
LT Debt$39,001$42,877$43,874$0
Deferred Rev, NC$16,147$32,323$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,702$2,713$1,533$2,176
Total NC Liab.$58,850$77,913$45,407$2,176
Other Liabilities$0$0$0$0
Cap. Leases$42,715$46,039$47,001$0
Total Liabilities$215,796$124,505$70,976$18,814
Equity
Pref Stock$0$0$0$0
Common Stock$6$5$5$5
Retained Earnings-$438,588-$365,888-$230,536-$122,035
AOCI-$3,356-$2,724-$1,752-$2,021
Other Equity$664,874$547,857$503,696$471,566
Total Equity$222,936$179,250$271,413$347,515
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$438,732$303,755$342,389$366,329
Net Debt-$181,539-$82,062-$7,911-$346,071
Monte Rosa Therapeutics, Inc. (GLUE) Financial Statements & Key Stats | AlphaPilot